MetLife Inc (MET)
Official siteFINANCIAL SERVICES • INSURANCE - LIFE • NYSE
Market Cap: $64.51B
Last updated: Nov 17, 2026 at 4:30 PM ET
MetLife Inc (MET) Statistics
MetLife (MET) has a market cap of $64.51B. Its share count is down 4.62% from a year earlier.
Total Valuation
| Market Cap | $64.51B |
|---|---|
| Latest price (Nov 17, 2026) | $101.53 |
Key Dates
The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 3, 2026.
| Next Earnings Date | Feb 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Last Ex-Dividend Date | Nov 3, 2026 |
| Next Payment Date | Dec 8, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.8x and 2.9x. Its year-end P/E ranged from 6.9x to 11.7x from 2016 to 2025.
| P/E Ratio | 10.0x |
|---|---|
| Forward P/E | 9.8x |
| P/S Ratio | 0.8x |
| Forward P/S | 0.8x |
| P/B Ratio | 2.9x |
| P/TBV Ratio | 5.0x |
| P/OCF Ratio | 4.6x |
| PEG Ratio | 0.9 |
Price Statistics
The stock is up 30.05% over 52 weeks and trades 3.09% above its 50-day average.
| Beta (1Y) | 0.63 |
|---|---|
| 52-Week Change | +30.05% |
| 1-Month Change | +2.55% |
| 3-Month Change | +7.37% |
| 6-Month Change | +26.00% |
| 5-Year Change | +59.27% |
| 10-Year Change | +112.99% |
| Total Return (1Y) | +33.06% |
| Total Return (3Y CAGR) | +19.84% |
| Total Return (5Y CAGR) | +12.85% |
| Return vs SPY (1Y) | +24.14% |
| Max Drawdown (1Y) | -18.56% |
| Max Drawdown (3Y) | -22.14% |
| Sharpe Ratio (1Y) | 1.30 |
| Correlation with SPY (1Y) | 0.37 |
| 50-Day Average | $98.49 |
| 200-Day Average | $86.43 |
| 52-Week Range | $66.02 to $106.72 |
| RSI (14 Days) | 54.0 |
| Average Volume (20 Days) | 3.30M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Returns and Efficiency
Return on equity is 23.26% over the last 12 months, against a 5-year average of 12.29%.
| Return on Equity (ROE) | 23.26% |
|---|---|
| Return on Assets (ROA) | 0.69% |
| ROE (5Y Average) | 12.29% |
| ROA (5Y Average) | 0.61% |
| Asset Turnover | 0.11x |
Taxes
Income tax took 22.38% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.49B |
|---|---|
| Effective Tax Rate | 22.38% |
Scores
MET has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 4 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue of $83.27B over the last 12 months is up 15.62% from the 12 months before.
| Revenue | $83.27B |
|---|---|
| Revenue Growth (YoY) | +15.62% |
| Pretax Income | $6.66B |
| Net Income | $5.17B |
| Reported EPS (TTM) | $10.19 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 2.99% of the $744.61B in total assets.
| Shareholder Equity | $22.23B |
|---|---|
| Book Value Per Share | $35.37 |
| Tangible Book Value | $12.68B |
| Tangible Book Per Share | $20.18 |
| Cash and Equivalents | $19.79B |
| Total Debt | $40.43B |
| Net Debt | $20.64B |
| Net Debt Per Share | $32.85 |
| Total Assets | $744.61B |
| Total Liabilities | $721.89B |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | $13.99B |
|---|---|
| FCF Per Share | $22.17 |
| Dividends Paid | $1.66B |
| Share Repurchases | $2.59B |
Trailing 12 months through Sep 30, 2026.
Margins
| Pretax Margin | 8.00% |
|---|---|
| Net Margin | 6.21% |
| Operating Margin (5Y Average) | 7.95% |
| Net Margin (5Y Average) | 6.07% |
Growth
Revenue grew 2.31% a year over 3 years, and EPS 8.80% a year.
| Revenue Growth (3Y CAGR) | +2.31% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.72% |
| EPS Growth (3Y CAGR) | +8.80% |
| EPS Growth (5Y CAGR) | +7.38% |
| FCF Growth (3Y CAGR) | +9.43% |
| FCF Growth (5Y CAGR) | +18.32% |
| Operating Income Growth (3Y CAGR) | -9.86% |
| Book Value Per Share Growth (2Y CAGR) | +2.99% |
| Tangible Book Per Share Growth (2Y CAGR) | +0.67% |
Dividends and Yields
MET pays out 28.51% of earnings as dividends.
| Dividend Per Share (Annual) | $2.37 |
|---|---|
| Dividend Yield | 2.33% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +4.31% |
| Dividend Growth (5Y CAGR) | +4.31% |
| Payout Ratio | 28.51% |
| Earnings Yield | 10.00% |
| Buyback Yield | 4.06% |
| Shareholder Yield | 6.42% |
Peer Position
Against 11 similar companies, MET has the 9th highest P/E.
P/E RatioPeer median 11.7x
P/S RatioPeer median 1.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +4.13%
Dividend YieldPeer median 2.33%
| P/E Ratio | 10.0x vs 11.7x median |
|---|---|
| P/S Ratio | 0.8x vs 1.6x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +15.62% vs +4.13% median |
| Dividend Yield | 2.33% vs 2.33% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.45% and EPS growth at 12.66% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.45% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.66% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MET
What is MET's market cap?
MetLife has a market cap of $64.51B.
What is MET's P/E ratio?
MetLife has a trailing P/E ratio of 10.0x and a forward P/E of 9.8x.
How many shares of MET are outstanding?
MetLife has 628.44M shares outstanding. The count is down 4.62% from a year earlier.
Does MET pay a dividend?
Yes. MetLife pays $2.37 a share a year, a dividend yield of 2.33%.
MET pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts